Pontifax Ltd. is a life sciences venture capital firm that specializes in investing in and nurturing early-stage companies in the healthcare sector. The firm focuses on innovative therapeutics, medical devices, and diagnostics, aiming to address significant unmet medical needs and improve patient care.

Tomer Kariv

Ran Nussbaum

Pontifax Ltd.

Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $1.2 billion under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing managements to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.

UroGen Pharma

VBI Vaccines

89bio

Amolyt Pharma

Rewalk Robotics

Check-Cap

Collplant

Prevail Therapeutics

ProQR Therapeutics

Keros Therapeutics

LogicBio Therapeutics

Silverback Therapeutics

Dynacure

Mereo Biopharma

Eloxx

Neogene Therapeutics

Pontifax Venture Capital

Metric
Company Name	Pontifax Ltd.
Symbol
MSH ID	COM:PONTIFAX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare
Country	IL
Stage
Employee Count	8
Website	pontifax.com
LinkedIn	pontifax-venture-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PONTIFAX

Pontifax Ltd.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue